" 343.22 
permitted combinations of active ingredients for cardiovascular-rheumatologic use. 
combinations containing aspirin must meet the standards of an acceptable dissolution test, as set forth in  343.90. the following combinations are permitted: aspirin identified in  343.12 and 343.13 may be combined with any antacid ingredient identified in  331.11 of this chapter or any combination of antacids permitted in accordance with  331.10(a) of this chapter provided that the finished product meets the requirements of  331.10 of this chapter and is marketed in a form intended for ingestion as a solution.", 
